A detailed history of California State Teachers Retirement System transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 24,411 shares of TARS stock, worth $809,224. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,411
Previous 22,281 9.56%
Holding current value
$809,224
Previous $809,000 18.05%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$25.17 - $38.73 $53,612 - $82,494
2,130 Added 9.56%
24,411 $663,000
Q1 2024

May 15, 2024

SELL
$19.61 - $39.22 $25,669 - $51,338
-1,309 Reduced 5.55%
22,281 $809,000
Q4 2023

Feb 13, 2024

SELL
$12.98 - $20.73 $22,507 - $35,945
-1,734 Reduced 6.85%
23,590 $477,000
Q3 2023

Nov 14, 2023

BUY
$14.75 - $24.62 $49,737 - $83,018
3,372 Added 15.36%
25,324 $450,000
Q2 2023

Aug 21, 2023

SELL
$11.57 - $19.63 $960 - $1,629
-83 Reduced 0.38%
21,952 $396,000
Q1 2023

May 09, 2023

SELL
$11.92 - $16.27 $3,921 - $5,352
-329 Reduced 1.47%
22,035 $276,000
Q4 2022

Feb 14, 2023

BUY
$14.12 - $18.72 $213,353 - $282,859
15,110 Added 208.3%
22,364 $327,000
Q3 2022

Nov 18, 2022

SELL
$14.08 - $18.5 $7,025 - $9,231
-499 Reduced 6.44%
7,254 $124,000
Q2 2022

Aug 15, 2022

BUY
$11.08 - $19.08 $45,849 - $78,953
4,138 Added 114.47%
7,753 $113,000
Q1 2022

May 16, 2022

SELL
$14.49 - $24.28 $14,852 - $24,887
-1,025 Reduced 22.09%
3,615 $61,000
Q4 2021

Feb 15, 2022

BUY
$21.21 - $29.68 $2,545 - $3,561
120 Added 2.65%
4,640 $104,000
Q3 2021

Nov 15, 2021

SELL
$21.45 - $29.22 $152,809 - $208,163
-7,124 Reduced 61.18%
4,520 $97,000
Q2 2021

Aug 16, 2021

BUY
$27.16 - $38.59 $63,690 - $90,493
2,345 Added 25.22%
11,644 $337,000
Q4 2020

Feb 16, 2021

BUY
$19.17 - $49.62 $178,261 - $461,416
9,299 New
9,299 $384,000

Others Institutions Holding TARS

About Tarsus Pharmaceuticals, Inc.


  • Ticker TARS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,658,500
  • Market Cap $884M
  • Description
  • Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...
More about TARS
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.